logo
Florida farm's cucumber recalls hit Walmart, Publix, others over salmonella

Florida farm's cucumber recalls hit Walmart, Publix, others over salmonella

Miami Herald29-05-2025

Ripple recalls from yet another salmonella outbreak traced to a Florida grower's cucumbers are washing over Kroger, Walmart, BJ's Wholesale Club, Weis Markets, Tops and various brands.
Delray Beach's Bedner Growers did the cucumber growing, Delray's Fresh Start Produce did the cucumber distributing and, now, multiple companies are doing the recalling after an outbreak that the FDA and CDC say has reached 15 states.
READ MORE: Palm Beach grower linked again to cucumber salmonella outbreak in several states
The Publix-related recalls
▪ Whole cucumbers, sold May 14-20.
▪ Whole cucumbers with Tajin, sold May 17-23.
▪ Watermelon Onion Feta, sold May 17-23.
▪ Watermelon Feta Berry, sold May 17-23.
▪ Spinach Salad, regular and large, sold May 17-23.
▪ Garden Salad, regular and large, sold May 17-23.
Though Bedner Growers and Fresh Start Produce are based in Publix's home state of Florida, this involves Publix stores only in North Carolina, South Carolina, Tennessee and Virginia.
READ MORE: 204,900 cans of beef stew recalled after customers unexpectedly got wood
The Kroger-related recalls
On Monday, Supreme Service Solutions recalled 16 of its Supreme Produce brand products sold in grab-and-go plastic containers at Kroger stores and Kroger-owned stores ( Ralphs, Harris Teeter, Dillons, King Soopers, Fred Meyer) from May 8 through May 21. For a full list of salads, trays and bowls, check out Supreme's FDA-posted recall notice.
These went to stores in Missouri, Kentucky, Mississippi, Illinois, Indiana, Ohio, Tennessee, Arkansas and Michigan.
Whole cucumbers, Deli Spring Mix Salad Trays, Deli Fresh Vegetable Trays, BRHD Hummus Vegetable Platters, small and medium, got recalled last week from Kroger and Kroger-related stores in Mississippi, Tennessee, Arkansas and Western Kentucky.
MORE: Silence on an E. Coli outbreak shows how changes under Trump affect food safety
The Deli salad recalls
Pennsylvania-based Isabelle's Kitchen recalled 946 cases of deli salads with Bedner cucumbers, salads that went to Florida, North Carolina, South Carolina, Pennsylvania, New Hampshire, New Jersey and Virginia.
▪ Kings: Greek Pasta Salad, Julian code 134, use by June 1.
▪ Isabelle's Kitchen Inc: Greek Pasta Salad, Julian code 134, use by June 1; Julian code 135, use by June 2.
▪ Maple Avenue Foods: Mediterranean Pasta Salad, Julian code 134, use by May 30; Julian code 134, use by May 31; Cruncy Wheatberry Salad, Julian code 134, use by June 1; Quinoa Tabouli, Julian code 134, use by May 30; Julian code 135, use by May 31; and Powerhouse Wheatberry Salad Kit, Julian code 134, use by May 27; Julian code 135, use by May 28; Julian code 136, use by May 29.
Direct questions about this recall to Isabelle's at 800-355-7252 from 8 a.m. to 5 p.m., Eastern time.
The Walmart-related recalls
Whole cucumbers sold from April 29 through May 14 in Florida, North Carolina, South Carolina, Missouri, Kentucky, Georgia, Texas, Pennsylvania, Mississippi, Illinois, Alabama, Arkansas, Delaware, Iowa, Indiana, Kansas, Louisiana, Maryland, New Jersey, New York, Ohio, Tennessee, Virginia, West Virginia and Puerto Rico
Marketside Fresh Cut Cucumber slices in 1.5-pound containers, all date codes up to May 24, went to certain Texas stores from May 13 through May 20.
If you're not sure whether or not you bought what's been recalled, contact Walmart either through its online customer help or 800-925- 6278.
Other brands or chain-linked products recalled
The Coastal Companies made the below products, which were distributed by Maryland's East Coast Fresh and Hearn Kirkwood from May 6 through May 21 in North Carolina, Pennsylvania, Delaware, Maryland, Massachusetts, Michigan, New Jersey, Ohio, Vermont, Virginia, West Virginia and Washington, D.C.
All lot numbers of each product have been recalled.
Tops: 1-pound containers of hot and mild salsa sold under the store brand for the New York, Pennsylvania and Vermont chain.
Wellsley Farms: Mild salsa sold under BJ's Warehouse Club's house brand.
Weis Markets: Mild salsa sold under Weis' store brand.
Giant: Salsa and Salsa Hot sold under the chain's store brand.
East Cost Fresh: 1-pound container of salsa.
Jack and Olive: 8-ounce containers of The House Salad
Spring and Sprout: 8-ounce containers of The House Salad
Created Fresh: The House Salad, Mini Garden Salad, Chicken Salad on Everything Ficelle, Tuna Salad on Everything Ficelle and Southwestern Breakfast Bowls.
Questions about these recalls can be sent to ECFCCustomers@CoastalSunbelt.com or call 410-133-8000.
What is salmonella?
Salmonella is one of the most common foodborne diseases, infecting about 1.35 million people in the United States each year, according to the CDC. About 26,000 of those people get hospitalized and 420 die. Salmonella outbreak sickness counts tend to be inaccurate on the low side because the vast majority of people recover without hospitalization.
Usually, salmonella means four to seven days of diarrhea, fever and stomachaches, starting anywhere from six hours to six days after eating something with salmonella.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP
Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP

Yahoo

time6 hours ago

  • Yahoo

Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP

On June 4, 2025, Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler Scientific, Inc. (NASDAQ:SMLR), misled investors about its business operations regarding claims tied to its QuantaFlo diagnostic device. A doctor in focus surrounded by colleagues in a hospital setting. In an annual report filed by Semler Scientific, Inc. (NASDAQ:SMLR) on February 28, 2025, the company disclosed that the U.S. Department of Justice (DOJ) was evaluating a potential False Claims Act case. The report triggered immediate market reaction, with the company's shares plummeting by 9.4% to close at $38.89 on March 3. Initiating the inquiry, Edelson Lechtzin LLP has asked for the public and stakeholders' help. Edelson urges those with non-public information regarding Semler Scientific, Inc. (NASDAQ:SMLR) to come forward and assist them in the investigation. It also encourages the company's investors who have suffered losses to follow the inquiry to learn more. The investor confidence has been significantly fluctuating since the disclosure. The stock's performance, which gained 6.49% last month, declined by 13.46% last week. The California-based company, Semler Scientific, Inc. (NASDAQ:SMLR), is known for developing non-invasive medical tools, with QuantaFlo being its most prominent product. Focusing on early disease detection and chronic condition management, the company has positioned itself between healthcare and technology. While we acknowledge the potential of SMLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Protect Our Care Iowa speaks out about Big, Beautiful, Bill
Protect Our Care Iowa speaks out about Big, Beautiful, Bill

Yahoo

time7 hours ago

  • Yahoo

Protect Our Care Iowa speaks out about Big, Beautiful, Bill

SIOUX CITY, Iowa (KCAU) — A Sioux City City councilmember is speaking out about President Trump's One Big Beautiful Bill Act and the proposed Medicaid cuts in the measure. Alex Watters spoke in a 'Protect Our Care Iowa' press conference on Zoom earlier this morning. According to a recent report by the non-partisan Congressional Budget Office, about 8 million people would lose Medicaid coverage because of added eligibility checks and strict work requirements in the next decade. Story continues below Top Story: McCook Lake residents in need of more dirt to rebuild homes Lights & Sirens: Traffic violation scam alarms Siouxlanders; police issue alert Sports: Bishop Heelan girls soccer drops 1A State semifinal match to Davenport Assumption in 1-0 defeat Weather: Get the latest weather forecast here The proposed cuts would affect more than 600k Iowans. 'Protect Our Care Iowa' says that 81k of those people face disabilities. Council member Watters says the bill shifts the wealth in the U.S. 'We're asking our elected officials to do what's right. They need to keep these essential services and stop hiding behind excuses of waste, fraud, and abuse. This is just an opportunity to take advantage of those that have little and are working hard, and give it to those that have plenty.' The U.S. Congress Joint Economic Committee says in its March 2025 report that Medicaid covers more than 350k people in Nebraska, and nearly 130k South Dakotans. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Eli Lilly (LLY)'s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating
Eli Lilly (LLY)'s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating

Yahoo

time7 hours ago

  • Yahoo

Eli Lilly (LLY)'s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating

On June 5, TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy rating on the stock. This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT trial. TD Cowen's analysis demonstrates that LLY's tirzepatide needs to match a MACE hazard ratio of 0.9 or better to statistically outperform dulaglutide. A scientist in a lab running tests on a variety of biopharmaceuticals. The investment firm hosted a survey of key opinion leaders, where 92% of the participants said they estimate a hazard ratio of 0.85 or better. Despite the positive outlook among survey respondents, investors remain wary about the possibility of attaining superiority over dulaglutide. Analysts also reworked their financial model for Eli Lilly and Company (NYSE:LLY) after the latest company updates and the Q1 2025 results. The 2026 EPS figures have been trimmed to $29.15, down by $0.25. The stock is now trading at a P/E ratio of 62.07, implying strong growth estimates. Eli Lilly and Company (NYSE:LLY) is a major global pharma giant based in Indianapolis that develops and commercializes medicines for diabetes, cancer, obesity, and autoimmune diseases. While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store